Product Information

BRIMONIDINE-TIMOLOL 0.2%-0.5% is a generic product labeled by Somerset Therapeutics, LLC, priced at $2.0756 per ML under NDC 70069065301. Its NADAC has been published 77 times since Jun 4, 2025.

FDA first approved this application on Sep 10, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIMONIDINE-TIMOLOL 0.2%-0.5%

Brimonidine Tartrate and Timolol Maleate
$2.0756per ML

Strength

2; 5 mg/mL; mg/mL

NDC

70069065301

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA216114

FDA Approved

9/10/2024

TE Code

AB

On Market Since

10/10/2024

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Antagonists
alpha-Adrenergic Agonist
beta-Adrenergic Blocker

Price Statistics

The NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has been published 77 times since Jun 4, 2025, and over the history we have for it it has declined 73.7%. The table below summarizes its recorded NADAC range and movement.

Current price$2.0756 per ML
All-time high$7.8815 (Jun 11, 2025)
All-time low$1.8390 (Aug 19, 2026)
52-week high$6.2321
52-week low$1.8390
Median price$2.5305
Average price$4.0020
Largest weekly change-35.8% (Dec 17, 2025)
Weeks tracked77
Tracking sinceJun 4, 2025

Price History

1W

+1.7%

1M

+5.3%

3M

+12.9%

6M

-12.9%

1Y

-69.8%

3Y

N/A

5Y

N/A

All

-73.7%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRIMONIDINE-TIMOLOL 0.2%-0.5%?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE-TIMOLOL 0.2%-0.5%, manufactured by Somerset Therapeutics, LLC, is $2.0756 per ML (NDC 70069065301), effective Nov 18, 2026.

How has the price of BRIMONIDINE-TIMOLOL 0.2%-0.5% changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has declined 73.7%. It has been tracked across 77 weekly CMS publications since Jun 4, 2025.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Since Jun 4, 2025, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has ranged from a low of $1.8390 (Aug 19, 2026) to a high of $7.8815 (Jun 11, 2025), with a median of $2.5305 per ML.

Are there cheaper alternatives to BRIMONIDINE-TIMOLOL 0.2%-0.5%?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BRIMONIDINE-TIMOLOL 0.2%-0.5% in a comparable dosage form, but none are currently priced below it.

Who manufactures BRIMONIDINE-TIMOLOL 0.2%-0.5%?

BRIMONIDINE-TIMOLOL 0.2%-0.5% (NDC 70069065301) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.